Royal DSM and JLL Partners merge DSM Pharmaceutical Products and Patheon Inc. into new company in USD 2.6 billion transaction | EuropaWire

Royal DSM and JLL Partners merge DSM Pharmaceutical Products and Patheon Inc. into new company in USD 2.6 billion transaction

Published 22, November 2013 at 1333 × 2000 in Royal DSM and JLL Partners merge DSM Pharmaceutical Products and Patheon Inc. into new company in USD 2.6 billion transaction

Jim Mullen, currently CEO of Patheon, will be appointed CEO of NewCo upon completion of the transaction

Jim Mullen, currently CEO of Patheon, will be appointed CEO of NewCo upon completion of the transaction

Bookmark the permalink.

Comments are closed.